SARS-CoV-2 uses ACE2, an inhibitor of the Renin-Angiotensin-Aldosterone System (RAAS),
for cellular entry. Studies indicate that RAAS imbalance worsens the prognosis in COVID-…

Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious
short- and long-term complications. In clinical practice, there is a need for improved plasma …

Background High levels of D-dimer and low platelet counts are associated with poor outcome
in coronavirus disease 2019 (COVID-19). As anticoagulation appeared to improve survival…

Background Venous thromboembolism (VTE) diagnosis would greatly benefit from the
identification of novel biomarkers to complement D-dimer, a marker limited by low specificity. …

Introduction Heparin-Induced Thrombocytopenia (HIT) is a rare but serious immune-mediated
complication of heparin treatment. HIT is characterized by an acute, transient …

Background Patients with critical COVID-19 have a high risk of thromboembolism, but
intensified thromboprophylaxis has not been proven beneficial. The activity of low-molecular-…

Venous thromboembolism (VTE) is a complex, multifactorial problem, the development of
which depends on a combination of genetic and acqfiguired risk factors. In a Spanish …

Venous thromboembolism (VTE), comprising both deep vein thrombosis (DVT) and pulmonary
embolism (PE) is a common, multi-causal disease with potentially serious short- and long-…

Background Thrombosis is a major global disease burden with almost 60% of cases related
to underlying heredity and most cases still idiopathic. Synonymous single nucleotide …

Background Causes of death after first time community-acquired venous thromboembolism (VTE)
diagnosed in unselected patients at the emergency department (ED) was investigated. …